IRB

• This study has been approved by the Ohio State University Institutional Review Board, Protocol #2024H0193
• The formal name of the study is “Comparative Effectiveness Trial of Metformin versus Insulin for the Treatment of Gestational Diabetes”
• The Primary Investigators for the study are Dr. Mark Landon and Dr. Kartik Venkatesh

Informed Consent

As a participant, you should have received a copy of the Study Informed Consent Form which includes important information about the study and what to expect. If you have lost or misplaced this form, you may request a new copy by contacting the appropriate study team here.

Incentives

Participants will receive these incentives:

• $100 at the start
• $50 at 6 weeks after birth
• $125 at 2 years after birth
• An extra $50 for those who are chosen for and do an interview at 6 weeks after birth

If you are expecting but have not received your participation incentives, please contact the appropriate study team here.